Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 2
1944 1
1945 1
1948 1
1951 1
1954 1
1956 1
1957 1
1959 1
1960 2
1961 1
1962 6
1963 7
1964 1
1965 1
1966 2
1967 3
1968 3
1969 5
1970 2
1971 5
1972 13
1973 12
1974 8
1975 5
1976 6
1977 6
1978 11
1979 5
1980 11
1981 14
1982 21
1983 18
1984 23
1985 34
1986 23
1987 28
1988 22
1989 16
1990 26
1991 26
1992 25
1993 34
1994 31
1995 46
1996 48
1997 49
1998 43
1999 57
2000 58
2001 73
2002 124
2003 142
2004 139
2005 166
2006 194
2007 212
2008 206
2009 219
2010 248
2011 301
2012 305
2013 366
2014 381
2015 377
2016 345
2017 343
2018 342
2019 343
2020 393
2021 446
2022 31
Text availability
Article attribute
Article type
Publication date

Search Results

5,795 results
Results by year
Filters applied: . Clear all
Page 1
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors.
Desai J, Deva S, Lee JS, Lin CC, Yen CJ, Chao Y, Keam B, Jameson M, Hou MM, Kang YK, Markman B, Lu CH, Rau KM, Lee KH, Horvath L, Friedlander M, Hill A, Sandhu S, Barlow P, Wu CY, Zhang Y, Liang L, Wu J, Paton V, Millward M. Desai J, et al. Among authors: lin cc. J Immunother Cancer. 2020 Jun;8(1):e000453. doi: 10.1136/jitc-2019-000453. J Immunother Cancer. 2020. PMID: 32540858 Free PMC article. Clinical Trial.
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ).
Bang YJ, Golan T, Dahan L, Fu S, Moreno V, Park K, Geva R, De Braud F, Wainberg ZA, Reck M, Goff L, Laing N, Mi G, Oliveira JM, Wasserstrom H, Lin CC. Bang YJ, et al. Among authors: lin cc. Eur J Cancer. 2020 Sep;137:272-284. doi: 10.1016/j.ejca.2020.06.007. Epub 2020 Aug 19. Eur J Cancer. 2020. PMID: 32827847 Free article. Clinical Trial.
Transcription Factor Bhlhe40 in Immunity and Autoimmunity.
Cook ME, Jarjour NN, Lin CC, Edelson BT. Cook ME, et al. Among authors: lin cc. Trends Immunol. 2020 Nov;41(11):1023-1036. doi: 10.1016/j.it.2020.09.002. Epub 2020 Oct 7. Trends Immunol. 2020. PMID: 33039338 Free PMC article. Review.
Immunomodulatory Effects of Green Tea Polyphenols.
Wang S, Li Z, Ma Y, Liu Y, Lin CC, Li S, Zhan J, Ho CT. Wang S, et al. Among authors: lin cc. Molecules. 2021 Jun 20;26(12):3755. doi: 10.3390/molecules26123755. Molecules. 2021. PMID: 34203004 Free PMC article. Review.
5,795 results